Skip to main content

Seaport Therapeutics, Inc.

SPTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002042347

No open-market purchases or sales by Seaport Therapeutics, Inc. insiders were filed in the last 90 days; 54 institutions reported holding it in 13F filings for Q2 2026, worth $815.3M in total; no superinvestor holds it.

Superinvestors holding SPTX, Q2 2026

See all superinvestors

No superinvestor reported holding SPTX in Q2 2026.